These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 15592503

  • 21. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
    Ishii Y, Pirkmaier A, Alvarez JV, Frank DA, Keselman I, Logothetis D, Mandeli J, O'Connell MJ, Waxman S, Germain D.
    J Natl Cancer Inst; 2006 Sep 06; 98(17):1238-47. PubMed ID: 16954476
    [Abstract] [Full Text] [Related]

  • 22. STAT signaling in head and neck cancer.
    Song JI, Grandis JR.
    Oncogene; 2000 May 15; 19(21):2489-95. PubMed ID: 10851047
    [Abstract] [Full Text] [Related]

  • 23. [Constitutive activation of signal transducers and activators of transcription 3 and expression of its target gene products in human ESCC cell line].
    Wang XH, Li SS, Yan AH, Lu CX, Guo YP.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr 15; 26(4):441-4. PubMed ID: 16624747
    [Abstract] [Full Text] [Related]

  • 24. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells.
    Huang M, Page C, Reynolds RK, Lin J.
    Gynecol Oncol; 2000 Oct 15; 79(1):67-73. PubMed ID: 11006034
    [Abstract] [Full Text] [Related]

  • 25. RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells.
    Lee SO, Lou W, Qureshi KM, Mehraein-Ghomi F, Trump DL, Gao AC.
    Prostate; 2004 Sep 01; 60(4):303-9. PubMed ID: 15264241
    [Abstract] [Full Text] [Related]

  • 26. 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.
    Ricker JL, Chen Z, Yang XP, Pribluda VS, Swartz GM, Van Waes C.
    Clin Cancer Res; 2004 Dec 15; 10(24):8665-73. PubMed ID: 15623651
    [Abstract] [Full Text] [Related]

  • 27. Activation of signal transducers and activators of transcription 3 and overexpression of its target gene CyclinD1 in laryngeal carcinomas.
    Liu B, Ren Z, Shi Y, Guan C, Pan Z, Zong Z.
    Laryngoscope; 2008 Nov 15; 118(11):1976-80. PubMed ID: 18758380
    [Abstract] [Full Text] [Related]

  • 28. Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth.
    Leong PL, Andrews GA, Johnson DE, Dyer KF, Xi S, Mai JC, Robbins PD, Gadiparthi S, Burke NA, Watkins SF, Grandis JR.
    Proc Natl Acad Sci U S A; 2003 Apr 01; 100(7):4138-43. PubMed ID: 12640143
    [Abstract] [Full Text] [Related]

  • 29. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
    Sok JC, Coppelli FM, Thomas SM, Lango MN, Xi S, Hunt JL, Freilino ML, Graner MW, Wikstrand CJ, Bigner DD, Gooding WE, Furnari FB, Grandis JR.
    Clin Cancer Res; 2006 Sep 01; 12(17):5064-73. PubMed ID: 16951222
    [Abstract] [Full Text] [Related]

  • 30. Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesis.
    Greten FR, Weber CK, Greten TF, Schneider G, Wagner M, Adler G, Schmid RM.
    Gastroenterology; 2002 Dec 01; 123(6):2052-63. PubMed ID: 12454861
    [Abstract] [Full Text] [Related]

  • 31. Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors.
    Paner GP, Silberman S, Hartman G, Micetich KC, Aranha GV, Alkan S.
    Anticancer Res; 2003 Dec 01; 23(3B):2253-60. PubMed ID: 12894500
    [Abstract] [Full Text] [Related]

  • 32. Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model.
    Zhang X, Chen ZG, Choe MS, Lin Y, Sun SY, Wieand HS, Shin HJ, Chen A, Khuri FR, Shin DM.
    Clin Cancer Res; 2005 Sep 01; 11(17):6261-9. PubMed ID: 16144930
    [Abstract] [Full Text] [Related]

  • 33. Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma.
    Masuda M, Ruan HY, Ito A, Nakashima T, Toh S, Wakasaki T, Yasumatsu R, Kutratomi Y, Komune S, Weinstein IB.
    Oral Oncol; 2007 Sep 01; 43(8):785-90. PubMed ID: 17169602
    [Abstract] [Full Text] [Related]

  • 34. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.
    Wang MB, Yip HT, Srivatsan ES.
    Laryngoscope; 2001 Jun 01; 111(6):982-8. PubMed ID: 11404608
    [Abstract] [Full Text] [Related]

  • 35. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
    Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J.
    Cancer Res; 2006 Mar 01; 66(5):2544-52. PubMed ID: 16510571
    [Abstract] [Full Text] [Related]

  • 36. Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN.
    Sun X, Zhang J, Wang L, Tian Z.
    Cancer Lett; 2008 Apr 18; 262(2):201-13. PubMed ID: 18248786
    [Abstract] [Full Text] [Related]

  • 37. p12CDK2-AP1 gene therapy strategy inhibits tumor growth in an in vivo mouse model of head and neck cancer.
    Figueiredo ML, Kim Y, St John MA, Wong DT.
    Clin Cancer Res; 2005 May 15; 11(10):3939-48. PubMed ID: 15897596
    [Abstract] [Full Text] [Related]

  • 38. Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis.
    Kusaba M, Nakao K, Goto T, Nishimura D, Kawashimo H, Shibata H, Motoyoshi Y, Taura N, Ichikawa T, Hamasaki K, Eguchi K.
    J Hepatol; 2007 Oct 15; 47(4):546-55. PubMed ID: 17602782
    [Abstract] [Full Text] [Related]

  • 39. [Significance of phosphorylation of mitogen-activated protein kinase and signal transducer and activator of transcription 3 and cyclin D1 protein expression in Hodgkin's lymphomas].
    Luo HY, Wang HC, Li YN, Zheng H.
    Ai Zheng; 2003 Mar 15; 22(3):266-9. PubMed ID: 12654183
    [Abstract] [Full Text] [Related]

  • 40. Adenovirus-mediated expression of dominant negative c-myb induces apoptosis in head and neck cancer cells and inhibits tumor growth in animal model.
    Kim SY, Yang YS, Hong KH, Jang KY, Chung MJ, Lee DY, Lee JC, Yi HK, Nam SY, Hwang PH.
    Oral Oncol; 2008 Apr 15; 44(4):383-92. PubMed ID: 17690006
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.